Surendra Neupane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Surendra Neupane has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Aditi Shastri
Albert Einstein College of Medicine
27 shared publications - Alexandre Gaspar-Maia
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
27 shared publications - Amer A. Beg
Moffitt Cancer Center 1 Department of Immunology Tampa, Florida
27 shared publications - Amy F. McLemore
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
27 shared publications - Amy L. Aldrich
Clinical Science & Immunology Program, Moffitt Cancer Center, Tampa, Florida
27 shared publications - Ariel Quintana
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida
27 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
QRT-PCR primers for confirming MALAT1 knockout across transcript. (Related to Fig S7)
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
QRT-PCR primers for confirming MALAT1 knockout across transcript. (Related to Fig S7)
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 6 but which were not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 6 but which were not included in the main figure
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 1 but which were not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 1 but which were not included in the main figure
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 3 but which were not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 3 but which were not included in the main figure
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 5 but which were not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 5 but which were not included in the main figure
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 2 but which were not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 2 but which were not included in the main figure
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
QRT-PCR primer sequences (related to Fig 1, Fig S3, Fig S7)
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
QRT-PCR primer sequences (related to Fig 1, Fig S3, Fig S7)
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Taqman assays for murine cytokine gene expression (related to Fig S6)
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Taqman assays for murine cytokine gene expression (related to Fig S6)
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Guide RNA for T7 knockdown of TET2 (related to Fig 1, Fig S1)
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Guide RNA for T7 knockdown of TET2 (related to Fig 1, Fig S1)
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 4 but which was not included in the main figure
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
Contains data related to Figure 4 but which was not included in the main figure